Catalyst Wire Dossier Catalyst Wire Dossier

H5N1 influenza vaccine (trial)

Influenza vaccine, H5N1 · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for H5N1 influenza vaccine (trial), covering 2026-02-05 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults [Phase 1, Phase 2]

See pricing